Virologica Sinica

, Volume 31, Issue 6, pp 500–508

A new strategy for full-length Ebola virus glycoprotein expression in E.coli

  • Junjie Zai
  • Yinhua Yi
  • Han Xia
  • Bo Zhang
  • Zhiming Yuan
Research article

DOI: 10.1007/s12250-016-3845-y

Cite this article as:
Zai, J., Yi, Y., Xia, H. et al. Virol. Sin. (2016) 31: 500. doi:10.1007/s12250-016-3845-y

Abstract

Ebola virus (EBOV) causes severe hemorrhagic fever in humans and non-human primates with high rates of fatality. Glycoprotein (GP) is the only envelope protein of EBOV, which may play a critical role in virus attachment and entry as well as stimulating host protective immune responses. However, the lack of expression of full-length GP in Escherichia coli hinders the further study of its function in viral pathogenesis. In this study, the vp40 gene was fused to the full-length gp gene and cloned into a prokaryotic expression vector. We showed that the VP40-GP and GP-VP40 fusion proteins could be expressed in E.coli at 16 °C. In addition, it was shown that the position of vp40 in the fusion proteins affected the yields of the fusion proteins, with a higher level of production of the fusion protein when vp40 was upstream of gp compared to when it was downstream. The results provide a strategy for the expression of a large quantity of EBOV full-length GP, which is of importance for further analyzing the relationship between the structure and function of GP and developing an antibody for the treatment of EBOV infection.

Keywords

Ebola virus (EBOV) glycoprotein (GP) E.coli prokaryotic expression 

Copyright information

© Wuhan Institute of Virology, CAS and Springer Science+Business Media Singapore 2016

Authors and Affiliations

  • Junjie Zai
    • 1
    • 2
  • Yinhua Yi
    • 1
    • 2
  • Han Xia
    • 1
  • Bo Zhang
    • 3
  • Zhiming Yuan
    • 1
  1. 1.Key Laboratory of Agricultural and Environmental Microbiology, Wuhan Institute of VirologyChinese Academy of SciencesWuhanChina
  2. 2.University of Chinese Academy of SciencesBeijingChina
  3. 3.Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of VirologyChinese Academy of SciencesWuhanChina

Personalised recommendations